Skip to content

Prevention of tuberculosis in prisions.

Primary prophylaxis for prevention of TB in prison's populations.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-4n67h3
Enrollment
Unknown
Registered
2016-12-16
Start date
2017-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary tuberculosis.

Interventions

728 subjects will be recruited respecting the inclusion / exclusion criteria. These will be divided into two groups of 324 individuals, called experimental and control, respectively. A simple individu
Drug

Sponsors

Ministério da Ciência, Tecnologia, Inovações e Comunicações
Lead Sponsor
Universidade Federal de Mato Grosso do Sul
Collaborator
Universidade Federal da Grande Dourados
Collaborator
Fundação Oswaldo Cruz - Unidade Cerrado Pantanal
Collaborator

Eligibility

Sex/Gender
Male
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Minimum stay estimated at 24 months under a closed regime; age between 18 and 45 years; without active tuberculosis or previous use of isoniazid; without consuming alcohol at least 3 months.

Exclusion criteria

Exclusion criteria: Positive serology for HIV, hepatitis B and C; latent tuberculosis; liver enzymes three times the upper limit; use of any medication that influence the metabolism of P450 enzyme; acute or chronic renal failure; epilepsy; indigenous.

Design outcomes

Primary

MeasureTime frame
50% of latent tuberculosis infection after 12 months of imprisonment.;50% of active tuberculosis after 12 months of imprisonment.

Secondary

MeasureTime frame
Reduction of 50% of latent tuberculosis after 24 months of imprisonment.;Reduction of 50% of active tuberculosis after 24 months of imprisonment.

Countries

Brazil

Contacts

Public ContactJulio;Roberto Croda;Oliveira

Universidade Federal da Grande Dourados;Universidade Estadual de Mato Grosso do Sul

juliocroda@ufgd.edu.br;roberto@uems.br+55(67)34102325;+ 55 (67) 991423003

Outcome results

None listed

Source: REBEC (via WHO ICTRP)